Hikma Offers Update On Plans For Advair Rival
Targets Launch In ‘Early 2021’ As Firm Provides Trading Update
Hikma has provided a trading update that sheds fresh light on plans for its delayed Advair generic, as well as revealing some new launches.

Hikma has provided a trading update that sheds fresh light on plans for its delayed Advair generic, as well as revealing some new launches.